Reneo Pharmaceuticals
Stock Forecast, Prediction & Price Target
Reneo Pharmaceuticals Financial Estimates
Reneo Pharmaceuticals Revenue Estimates
Reneo Pharmaceuticals EBITDA Estimates
Reneo Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $52.93M Low: $52.93M High: $52.93M avg. 0% | Avg: $208.44M Low: $208.44M High: $208.44M avg. 293.76% | Avg: $424.85M Low: $424.85M High: $424.85M avg. 103.81% | |
Net Income
% change YoY
| $-39.77M N/A | $-50.06M -25.87% | $-77.38M -54.58% | Avg: $-23.6M Low: $-21.16M High: $-21.16M avg. 69.50% | Avg: $-21.93M Low: $-19.93M High: $-19.93M avg. 7.05% | Avg: $-87.12M Low: $-87.12M High: $-87.12M avg. -297.16% | |
EBITDA
% change YoY
| $-39.76M N/A | $-53.76M -35.18% | $-82.23M -52.96% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |
EPS
% change YoY
| -$2.19 N/A | -$2.04 6.84% | -$25.23 -1136.76% | Avg: -$0.69 Low: -$0.69 High: -$0.69 avg. 97.26% | Avg: -$0.65 Low: -$0.65 High: -$0.65 avg. 5.79% | Avg: -$2.84 Low: -$2.84 High: -$2.84 avg. -336.92% | |
Operating Expenses
% change YoY
| $39.81M N/A | $53.84M 35.23% | $83.05M 54.23% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |
FAQ
What is Reneo Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -73.53% in 2025-2027.
We have gathered data from 1 analysts. Their low estimate is -21.16M, average is -23.6M and high is -21.16M.
What is Reneo Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 132.52% in 2025-2027.
We have gathered data from 1 analysts. Their low revenue estimate is $52.93M, average is $52.93M and high is $52.93M.
What is Reneo Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -77.95% in 2025-2027.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.69, average is -$0.69 and high is $-0.69.
What is the best performing analyst?
In the last twelve months analysts have been covering Reneo Pharmaceuticals stock. The most successful analyst is Yasmeen Rahimi.